Understanding mechanistic relationships between IgG titers and Fc effector functions: a computational framework to assess polyfunctionality

IntroductionRecent vaccine and infectious disease studies have highlighted the importance of antibodies that activate cellular Fc functions, including antibody-dependent cellular phagocytosis (ADCP) and antibody-dependent cellular cytotoxicity (ADCC), which are mediated by different Fc gamma Recepto...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Suzanne K. Shoffner-Beck, Robert M. Theisen, Kade E. Wong, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Stephen Kent, Amy W. Chung, Kelly B. Arnold
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-09-01
Subjects:	antibody-mediated effector functions antibody-dependent cellular cytotoxicity (ADCC) human immunodeficiency virus (HIV) ordinary differential equation model mechanistic model
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1578500/full

Similar Items

Decay of Fc-dependent antibody functions after mild to moderate COVID-19
by: Wen Shi Lee, et al.
Published: (2021-06-01)

Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
by: Jennifer L. Schwedler, et al.
Published: (2024-12-01)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
by: Rena Liu, et al.
Published: (2020-11-01)

Fc-effector functional antibody assays for SARS-CoV-2 variants of concern
by: Xuemin Chen, et al.
Published: (2025-05-01)

Taking the Hinge off: An Approach to Effector-Less Monoclonal Antibodies
by: Jamie Valeich, et al.
Published: (2020-09-01)

Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
by: Josée Golay, et al.
Published: (2022-06-01)

Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodies
by: Erin Stefanutti, et al.
Published: (2025-09-01)

Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models
by: Alan L. Schmaljohn, et al.
Published: (2019-07-01)

Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques
by: Marina Tuyishime, et al.
Published: (2023-12-01)

Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody
by: Carina Lynn Gehlert, et al.
Published: (2022-08-01)

Effects of gp120 Inner Domain (ID2) Immunogen Doses on Elicitation of Anti-HIV-1 Functional Fc-Effector Response to C1/C2 (Cluster A) Epitopes in Mice
by: Rebekah Sherburn, et al.
Published: (2020-09-01)

Impact of an aerosolized or intramuscular adenovirus type 5-vectored COVID-19 vaccine on Fc-mediated immune effector functions in a hybrid immunity population
by: Mingzhi Gan, et al.
Published: (2025-10-01)

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
by: Bin Su, et al.
Published: (2019-12-01)

Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells
by: Kristin M. Snyder, et al.
Published: (2018-12-01)

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection
by: Srivamshi Pittala, et al.
Published: (2019-05-01)

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
by: Bronwyn M. Gunn, et al.
Published: (2021-11-01)

Development and Validation of Cell-Based Bioassay for the Detection of Neutralizing Antibodies to Ocrelizumab in Human Serum Using Antibody-Dependent Cell-Mediated Cytotoxicity Test in a Reporter Cell Line Expressing FcγRIIIa
by: Olga Strizhakova, et al.
Published: (2026-05-01)

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
by: Andréa Cottignies-Calamarte, et al.
Published: (2023-02-01)

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01)

Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
by: Shamus P. Keeler, et al.
Published: (2021-05-01)

One N-glycan regulates natural killer cell antibody-dependent cell-mediated cytotoxicity and modulates Fc γ receptor IIIa/CD16a structure
by: Paul G Kremer, et al.
Published: (2024-10-01)

Broadening anticancer spectrum by preprocessing and treatment of T- lymphocytes expressed FcγRI and monoclonal antibodies for refractory cancers
by: Lei Tang, et al.
Published: (2024-06-01)

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
by: Gillian Dekkers, et al.
Published: (2017-08-01)

iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
by: Kate J. Dixon, et al.
Published: (2024-07-01)

Impact of Vaccine-Elicited Anti-Spike IgG4 Antibodies on Fc-Effector Functions Against SARS-CoV-2
by: Katrina Dionne, et al.
Published: (2025-05-01)

Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design
by: Sinthujan Jegaskanda, et al.
Published: (2017-06-01)

Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
by: F. E. M. Scholte, et al.
Published: (2023-08-01)

Plant-Produced Anti-Zika Virus Monoclonal Antibody Glycovariant Exhibits Abrogated Antibody-Dependent Enhancement of Infection
by: Ming Yang, et al.
Published: (2023-03-01)

Evaluation of Poxvirus-Specific Antibody Response in Monkey Poxvirus-Negative and -Positive Cohorts
by: Nannan Jia, et al.
Published: (2025-07-01)

Effector mechanisms of influenza-specific antibodies: neutralization and beyond
by: Federica Sicca, et al.
Published: (2018-09-01)

Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects
by: Dhuha H Nawab
Published: (2021-12-01)

Multivalent Rhamnose‐Modified EGFR‐Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies
by: Yanchun Li, et al.
Published: (2024-04-01)

Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
by: Andrea R. Shiakolas, et al.
Published: (2021-06-01)

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling
by: Song Li, et al.
Published: (2023-10-01)

Fc-Mediated Effector Functions of Anti-NS1 Antibodies in Dengue
by: Romchat Kraivong
Published: (2025-09-01)

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
by: Bruce D. Wines, et al.
Published: (2023-01-01)

Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
by: Rebekah Sherburn, et al.
Published: (2021-08-01)

Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants
by: Robert Pejchal, et al.
Published: (2023-08-01)

Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
by: Charles D. Murin
Published: (2020-07-01)

A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults
by: Jinge Cao, et al.
Published: (2025-02-01)